Syneos Health Names Michelle Keefe as Next Chief Executive Officer
April 29, 2022 06:26 ET
|
Syneos Health, Inc.
Alistair Macdonald to Retire After 20 Years in Variety of Leadership Roles Michael Brooks Named Chief Operating Officer Company Reports First Quarter 2022 Results and Updates Full Year Guidance ...
Syneos Health Reports First Quarter 2022 Results
April 29, 2022 06:24 ET
|
Syneos Health, Inc.
Highlights Revenue for the first quarter of $1,336.3 million increased 10.5% on a reported basis and 11.7% on a constant currency basis year-over-year.Clinical Solutions net new business...
Syneos Health Reports Third Quarter 2021 Results
November 03, 2021 06:16 ET
|
Syneos Health, Inc.
Highlights Third quarter revenue of $1,348.2 million increased 22.7% year-over-year.Clinical Solutions net new business awards of $1,353.8 million for the third quarter, representing year-over-year...
Syneos Health Reports First Quarter 2021 Results
April 29, 2021 06:16 ET
|
Syneos Health, Inc.
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing a sequential increase of 6.0% compared to the three months ended December 31, 2020, and a...
Syneos Health® Launches Kinetic™ Omnichannel Capability to Accelerate Modern Customer Engagement
October 21, 2020 06:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 21, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today introduced Kinetic, a modern customer...
INC Research/inVentiv Health to Present at Upcoming J.P. Morgan Healthcare Conference
December 14, 2017 18:09 ET
|
INC Research, LLC
RALEIGH, N.C., Dec. 14, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive...
INC Research/inVentiv Health to Present at Upcoming Jefferies 2017 London Healthcare Conference
November 03, 2017 16:31 ET
|
INC Research, LLC
RALEIGH, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- INC Research/inVentiv Health (Nasdaq:INCR), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive...
INC Research to Present at Upcoming Nasdaq Investor Conference
November 14, 2016 16:15 ET
|
INC Research, LLC
RALEIGH, N.C., Nov. 14, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief...